|
시장보고서
상품코드
2055064
점안액 시장 : 유형별, 치료 용도별, 약제 클래스별, 방부제 유무별, 유형별, 제제별, 점도별, 유통 채널별, 최종 사용자별, 지역별Eye Drops Market, By Type, By Therapeutic Application, By Drug Class, By Preservative Status, By Type, By Formulation, By Viscosity, By Distribution Channel, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
점안액 시장은 2026년에 71억 1,000만 달러에 달하고 2033년까지 96억 1,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 4.4%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 71억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 4.40% | 시장 규모 예측(2033년) : | 96억 1,000만 달러 |
세계 점안액 시장은 안과 의약품 업계에서 매우 중요한 부분을 차지하고 있으며, 다양한 안과 질환을 치료하고 최적의 눈 건강을 유지하기 위해 고안된 다양한 치료 및 진단 솔루션을 포괄하고 있습니다.
점안액(안과용 용액이라고도 함)은 녹내장, 안구건조증, 알레르기성 결막염, 세균성 및 바이러스성 감염증, 염증 관련 질환 등을 치료하기 위한 약물의 주요 투여 경로로 사용되고 있습니다. 이 시장에는 처방약, 일반의약품, 그리고 인공눈물, 항히스타민제, 항생제, 항염증제, 녹내장 치료제 등의 특수 제제가 포함됩니다.
고령화, 화면 시청 시간 증가, 환경 오염 물질, 생활 방식의 변화 등의 요인으로 인해 안과 질환 유병률이 증가하고 있어, 효과적인 안과 치료에 대한 수요는 전 세계적으로 계속 높아지고 있습니다. 이 시장의 성장 추세는 약물 전달 시스템의 기술적 진보, 혁신적인 무방부제 제제, 그리고 환자의 복약 순응도와 치료 효과를 높이는 서방형 메커니즘의 개발에 힘입어 더욱 가속화되고 있습니다.
시장 역학
세계 점안액 시장은 국제 시장 전체의 성장을 주도하는 몇 가지 주요 시장 성장 촉진요인에 힘입어 성장하고 있습니다. 주요 성장 요인은 안과 질환, 특히 녹내장, 황반변성, 당뇨성 망막병증과 같은 노화와 관련된 질환의 유병률 증가에 있습니다. 이러한 현상은 인구 고령화가 진행됨에 따라 전 세계 수백만 명의 사람들에게 영향을 미치고 있습니다. 게다가 디지털 기기 사용이 급증함에 따라 컴퓨터 시력 증후군이나 안구건조증 사례가 급증하고 있어, 윤활 점안액이나 치료용 점안액에 대한 수요가 크게 증가하고 있습니다.
약물 전달 시스템 분야의 기술 혁신은 방부제 무첨가 제제 및 서방 메커니즘 등을 통해 환자의 복약 순응도와 치료 성과를 향상시켜 시장 성장을 더욱 촉진하고 있습니다. 그러나 시장에는 성장 가능성을 가로막는 중대한 제약 요인이 존재합니다. 안과용 제품에 대한 엄격한 규제 요건으로 인해 대규모 임상시험과 승인 절차가 필수적이며, 그 결과 개발 기간이 길어지고 막대한 자금 투자가 필요해지기 때문에 중소 제조업체 시장 진입을 저해할 가능성이 있습니다.
또한, 점안액에 포함된 특정 방부제와 관련된 오염 및 부작용의 위험은 환자와 의료 종사자들 사이에서 안전에 대한 우려를 불러일으키고 있습니다. 주요 브랜드 제품의 특허 만료 역시 경쟁을 심화시켜 제약사의 이익률을 떨어뜨리고 있습니다. 이러한 과제가 있음에도 불구하고, 이 시장에는 성장 기회와 혁신을 위한 큰 가능성이 존재합니다. 전 세계적으로 고령화가 진행됨에 따라 안과 치료에 대한 지속적인 수요가 발생하고 있습니다. 한편, 아시아태평양과 라틴아메리카의 신흥 시장에서는 의료 인프라의 개선과 눈 건강에 대한 인식 제고로 인해 미개척된 잠재력이 숨겨져 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 파라미터(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 세계 점안액 시장의 주요 기업 프로파일을 작성했습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 점안액 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 점안액 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 점안액 시장 : 유형별(2021-2033년)
제5장 세계의 점안액 시장 : 치료 용도별(2021-2033년)
제6장 세계의 점안액 시장 : 약제 클래스별(2021-2033년)
제7장 세계의 점안액 시장 : 방부제 유무별(2021-2033년)
제8장 세계의 점안액 시장 : 유형별(2021-2033년)
제9장 세계의 점안액 시장 : 제제별(2021-2033년)
제10장 세계의 점안액 시장 : 점도별(2021-2033년)
제11장 세계의 점안액 시장 : 유통 채널별(2021-2033년)
제12장 세계의 점안액 시장 : 최종 사용자별(2021-2033년)
제13장 세계의 점안액 시장 : 지역별(2021-2033년)
제14장 경쟁 구도
제15장 애널리스트의 제안
제16장 참고 문헌 및 조사 방법
KTH 26.06.19Eye Drops Market is estimated to be valued at USD 7.11 Bn in 2026 and is expected to reach USD 9.61 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.11 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.40% | 2033 Value Projection: | USD 9.61 Bn |
The global eye drops market represents a critical segment of the ophthalmic pharmaceutical industry, encompassing a diverse range of therapeutic and diagnostic solutions designed to address various ocular conditions and maintain optimal eye health.
Eye drops, also known as ophthalmic solutions, serve as the primary delivery mechanism for medications targeting conditions such as glaucoma, dry eye syndrome, allergic conjunctivitis, bacterial and viral infections, and inflammation-related disorders. The market encompasses prescription medications, over-the-counter solutions, and specialized formulations including artificial tears, antihistamines, antibiotics, anti-inflammatory agents, and glaucoma medications.
With the increasing prevalence of eye-related disorders driven by factors such as aging populations, prolonged screen time, environmental pollutants, and lifestyle changes, the demand for effective ophthalmic treatments continues to escalate globally. The market's growth trajectory is further supported by technological advancements in drug delivery systems, innovative preservative-free formulations, and the development of sustained-release mechanisms that enhance patient compliance and therapeutic efficacy.
Market Dynamics
The global eye drops market is propelled by several key drivers that collectively fuel its expansion across international markets. The primary growth driver stems from the rising prevalence of ocular disorders, particularly age-related conditions such as glaucoma, macular degeneration, and diabetic retinopathy, which affect millions of individuals worldwide as populations continue to age. Additionally, the exponential increase in digital device usage has led to a surge in computer vision syndrome and dry eye conditions, creating substantial demand for lubricating and therapeutic eye drops.
Technological innovations in drug delivery systems, including preservative-free formulations and extended-release mechanisms, enhance patient compliance and treatment outcomes, further driving market growth. However, the market faces significant restraints that challenge its expansion potential. Stringent regulatory requirements for ophthalmic products necessitate extensive clinical trials and approval processes, resulting in lengthy development timelines and substantial financial investments that may deter smaller manufacturers.
Furthermore, the risk of contamination and adverse reactions associated with certain preservatives in eye drops raises safety concerns among patients and healthcare providers. Patent expirations of major branded products also intensify competitive pressures and reduce profit margins for pharmaceutical companies. Despite these challenges, the market presents substantial opportunities for growth and innovation. The expanding geriatric population globally creates a sustained demand for ophthalmic treatments, while emerging markets in Asia Pacific and Latin America offer untapped potential due to improving healthcare infrastructure and rising awareness about eye health.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global eye drops market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include major pharmaceutical manufacturers, Alcon, AbbVie Inc (Allergan), Bausch Health Companies Inc, Johnson & Johnson Vision, Santen Pharmaceutical Co Ltd, Pfizer Inc, Bayer AG, Sun Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Rohto Pharmaceutical Co Ltd, Thea Pharma Inc, Similasan Corporation, Akorn Operating Company LLC, Prestige Consumer Healthcare Inc, and Jamjoom Pharmaceuticals.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global eye drops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eye drops market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Prescription Eye Drops
- Over-the-Counter (OTC) Eye Drops
- Therapeutic Application Insights (Revenue, USD Bn, 2021 - 2033)
- Dry Eye Disease (DED) Management
- Allergic Conjunctivitis Treatment
- Glaucoma & Ocular Hypertension
- Eye Infection Treatment (Bacterial, Viral, Fungal)
- Inflammation or Post-Surgical Care
- Mydriasis or Cycloplegia
- Diagnostic Dye Solutions
- Post-Operative Care (Anesthetic Drops)
- Uveitis
- Other Retinal Disorders
- Drug Class Insights (Revenue, USD Bn, 2021 - 2033)
- Lubricants and Emollients
- Antihistamines
- Mast Cell Stabilizers
- Corticosteroids
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Prostaglandin Analogs
- Beta-Blockers
- Alpha Agonists
- Carbonic Anhydrase Inhibitors
- Antibiotics
- Antivirals
- Antifungals
- Vasoconstrictors
- Combination Drugs
- Preservative Status Insights (Revenue, USD Bn, 2021 - 2033)
- Preserved Eye Drops
- Preservative-Free Eye Drops
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Brand
- Generics
- Formulation Insights (Revenue, USD Bn, 2021 - 2033)
- Solution
- Suspension
- Emulsion
- Viscosity Insights (Revenue, USD Bn, 2021 - 2033)
- Low Viscosity
- Medium Viscosity
- High Viscosity
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Ophthalmology Clinics
- Others (Ambulatory Surgery Centers)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Alcon
- AbbVie Inc (Allergan)
- Bausch Health Companies Inc
- Johnson & Johnson Vision
- Santen Pharmaceutical Co Ltd
- Pfizer Inc
- Bayer AG
- Sun Pharmaceutical Industries Ltd
- Otsuka Pharmaceutical Co Ltd
- Rohto Pharmaceutical Co Ltd
- Thea Pharma Inc
- Similasan Corporation
- Akorn Operating Company LLC
- Prestige Consumer Healthcare Inc
- Jamjoom Pharmaceuticals
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Eye Drops Market, By Type
- Global Eye Drops Market, By Therapeutic Application
- Global Eye Drops Market, By Drug Class
- Global Eye Drops Market, By Preservative Status
- Global Eye Drops Market, By Type
- Global Eye Drops Market, By Formulation
- Global Eye Drops Market, By Viscosity
- Global Eye Drops Market, By Distribution Channel
- Global Eye Drops Market, By End User
- Global Eye Drops Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Eye Drops Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Prescription Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Over-the-Counter (OTC) Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Eye Drops Market, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Dry Eye Disease (DED) Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Allergic Conjunctivitis Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Glaucoma & Ocular Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Eye Infection Treatment (Bacterial, Viral, Fungal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Inflammation or Post-Surgical Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Mydriasis or Cycloplegia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Dye Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Post-Operative Care (Anesthetic Drops)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Uveitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Retinal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Eye Drops Market, By Drug Class, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Lubricants and Emollients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Mast Cell Stabilizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Prostaglandin Analogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Beta-Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Alpha Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Carbonic Anhydrase Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Antifungals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Vasoconstrictors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Combination Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Eye Drops Market, By Preservative Status, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Preserved Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Preservative-Free Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Eye Drops Market, By Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Brand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Generics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Eye Drops Market, By Formulation, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Emulsion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Eye Drops Market, By Viscosity, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Low Viscosity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Medium Viscosity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- High Viscosity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Eye Drops Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
12. Global Eye Drops Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ophthalmology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Ambulatory Surgery Centers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
13. Global Eye Drops Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
14. Competitive Landscape
- Alcon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc (Allergan)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bausch Health Companies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Vision
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Santen Pharmaceutical Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Otsuka Pharmaceutical Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Rohto Pharmaceutical Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thea Pharma Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Similasan Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Akorn Operating Company LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Prestige Consumer Healthcare Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jamjoom Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
15. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
16. References and Research Methodology
- References
- Research Methodology
- About us
